Top Transthyretin Amyloidosis Treatment Companies, Leaders & Major Players

This list of the top companies of Transthyretin Amyloidosis Treatment is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Transthyretin Amyloidosis Treatment sector.

Top Transthyretin Amyloidosis Treatment Companies

  1. Pfizer

  2. Alnylam Pharmaceuticals

  3. Intellia Therapeutics, Inc.

  4. AstraZeneca

  5. BridgeBio Pharma Inc

*Disclaimer: Top companies sorted in no particular order

Transthyretin Amyloidosis Treatment Market Major Players

Transthyretin Amyloidosis Treatment - Competitive Concentration

Transthyretin Amyloidosis Treatment Market Concentration

List of Transthyretin Amyloidosis Treatment Companies

  • Pfizer

  • Alnylam Pharmaceuticals Inc

  • AstraZeneca

  • BridgeBio Pharma Inc

  • Intellia Therapeutics Inc

  • Alexion Pharmaceuticals

  • Prothena Corp

  • Corino Therapeutics Inc

  • Takeda Pharmaceutical Co Ltd

  • CRISPR Therapeutics AG

  • CSL Vifor

  • Eidos Therapeutics

  • Silence Therapeutics

  • Sanofi

  • Vertex Pharmaceuticals

  • Regeneron Pharmaceuticals

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds